Venus Remedies has announced a final dividend of ₹10 per equity share, equivalent to 100% of the face value, subject to shareholder approval at the forthcoming 37th Annual General Meeting (AGM). The AGM is scheduled for 20th August 2026 and will be conducted via video conferencing in line with the Ministry of Corporate Affairs’ guidelines. The record date to determine eligible shareholders for the dividend is set for 7th August 2026. Once approved, the dividend will be disbursed within 30 days from the AGM date, after the necessary tax deductions.
Additionally, Venus Remedies has confirmed several key appointments. The company has appointed M/s C. L Bansal & Associates as Cost Auditors and M/s Mehra Goel & Co as Internal Auditors for the financial year 2026-27. These appointments were made following the recommendations from the respective committees.
The company also announced the adoption of new Memorandum and Articles of Association in accordance with the Companies Act 2013. This update is aimed at aligning the company’s governance documents with the latest regulatory requirements.
Furthermore, Venus Remedies has implemented a trading window closure from 1st April 2026, which will remain in effect until 48 hours after the financial results are announced.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).